AzTrials
AzTrials

Cardiac ArrestNCT04660526

RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems

A study testing Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators, Systematic bystander resuscitation instruction by 911 operators and Comprehensive community training of lay people in CPR and AED use. in people with Cardiac Arrest, run by Duke University at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

RACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Cardiac Arrest
What is being tested?
Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators, Systematic bystander resuscitation instruction by 911 operators and Comprehensive community training of lay people in CPR and AED use.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20,000 participants
Where
1 siteUnited States
Study dates
1 Jul 2022to 30 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • OHCA of non-traumatic etiology
  • Patients who are pulseless on arrival of a first responder; or patients who become pulseless in the presence of a first responder; OR patients who have a pulse on arrival of EMS, where a successful defibrillation was previously administered by a bystander or first responder.

Who cannot join

  • Untreated cardiac arrests, including arrests in which resuscitation efforts are not initiated or are terminated immediately upon arrival of EMS because the patient is not a viable candidate for resuscitation due to:
  • injuries incompatible with life,
  • the presence of rigor mortis or lividity,
  • signs of decomposition, or
  • the presence of a valid DNR.
  • Private EMS transport that did not involve 911 dispatch (example: interfacility transport between nursing home and hospital).
  • Arrest of clear and obvious traumatic etiology
  • Bystander suspected cardiac arrest, where ROSC was achieved without the need for defibrillation or first responder CPR

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke

    Durham, North Carolina, 27705

Other trials in United States

About this study

Official title: RAndomized Cluster Evaluation of Cardiac ARrest Systems

RACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. RACE-CARS will enroll 50 counties in North Carolina that are estimated to have a total of approximately 20,000 patients with cardiac arrest over a 4-year intervention period. County "clusters" will be randomized in a 1:1 ratio to intervention versus usual care. The trial duration is 7 years, which includes a 6-month start-up (including recruitment and randomization) period, a 12-month intervention training phase, a 4-year intervention period, a 12-month follow-up for to assess quality of life in survivors of OHCA, and a 6-month close-out and data analysis period.

Conditions
Cardiac Arrest
Being tested
Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators, Systematic bystander resuscitation instruction by 911 operators, Comprehensive community training of lay people in CPR and AED use., Optimized first responder performance including earlier use of AEDs.
Keywords
cardiac arrest, cardiopulmonary resuscitation, telephone CPR, dispatch CPR, out-of-hospital cardiac arrest, defibrillation
Medical subject headings
Heart Arrest, Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operatorsOther

    EMS first responders will recognize cardiac arrest and respond immediately, increasing time to dispatch

  • Systematic bystander resuscitation instruction by 911 operatorsOther

    911 operators will be able to describe how to administer CPR over the phone.

  • Comprehensive community training of lay people in CPR and AED use.Other

    Training of lay people regarding CPR and AED use.

  • Optimized first responder performance including earlier use of AEDs.Other

    First responders will recognize where AEDs are located and use them appropriately

Study groups in NCT04660526
Study groupRoleWhat they receive
Intervention (Enhanced Standard of Care)ExperimentalMass community CPR/AED training, optimize 911 medical dispatch, improve first responder performance
Receives: Other: Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators; Other: Systematic bystander resuscitation instruction by 911 operators; Other: Comprehensive community training of lay people in CPR and AED use.; Other: Optimized first responder performance including earlier use of AEDs.
Control (Standard of Care)No interventionUsual care, continuing standard quality improvement effort

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Survival with good neurologic outcomes as measured by a CPC score of 1 or 2 at discharge

    Cerebral Performance Category (CPC)

    Measured: up to 12months

Secondary outcomes (2)
  1. Percent of patients who receive CPR from a bystander as measured by EMS report

    Measured: Baseline

  2. Rate of Defibrillation before paramedics arrive as measured by bystander interview

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2020
  2. Study start1 Jul 2022
  3. Primary completion30 Sep 2026
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04660526
Sponsor's protocol ID
Pro00105633
Other IDs
5UH3HL146935-06, 5U24HL146938-06
Status last verified
Jul 2026
First submitted
3 Dec 2020
Last updated
28 Oct 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Krychtiuk KA, Starks MA, Al-Khalidi HR, Mark DB, Monk L, Yow E, Kaltenbach L, Jollis JG, Al-Khatib SM, Bosworth HB, Ward K, Brady S, Tyson C, Vandeventer S, Baloch K, Oakes M, Blewer AL, Lewinski AA, Hansen CM, Sharpe E, Rea TD, Nelson RD, Sasson C, McNally B, Granger CB; RACE-CARS NC Counties. RAndomized Cluster Evaluation of Cardiac ARrest Systems (RACE-CARS) trial: Study rationale and design. Am Heart J. 2024 Nov;277:125-137. doi: 10.1016/j.ahj.2024.07.013. Epub 2024 Jul 30.

    PubMed 39084483

Questions about this trial

What is this clinical trial studying?

A study testing Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators, Systematic bystander resuscitation instruction by 911 operators and Comprehensive community training of lay people in CPR and AED use. in people with Cardiac Arrest, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 28 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Survival with good neurologic outcomes as measured by a CPC score of 1 or 2 at discharge (time frame: up to 12months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04660526, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in